Report cover image

Global EPA & DHA (Omega 3) Ingredients Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 197 Pages
SKU # APRC20556592

Description

Summary

According to APO Research, the global EPA & DHA (Omega 3) Ingredients market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for EPA & DHA (Omega 3) Ingredients is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for EPA & DHA (Omega 3) Ingredients is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the EPA & DHA (Omega 3) Ingredients market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for EPA & DHA (Omega 3) Ingredients is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the EPA & DHA (Omega 3) Ingredients market include Lonza, Omega Protein, Martek, GC Rieber Oils, DSM, Croda, BASF, Axellus and Algae EPAX, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for EPA & DHA (Omega 3) Ingredients, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of EPA & DHA (Omega 3) Ingredients, also provides the sales of main regions and countries. Of the upcoming market potential for EPA & DHA (Omega 3) Ingredients, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the EPA & DHA (Omega 3) Ingredients sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global EPA & DHA (Omega 3) Ingredients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for EPA & DHA (Omega 3) Ingredients sales, projected growth trends, production technology, application and end-user industry.

EPA & DHA (Omega 3) Ingredients Segment by Company

Lonza
Omega Protein
Martek
GC Rieber Oils
DSM
Croda
BASF
Axellus
Algae EPAX
Aker BioMarine
EPA & DHA (Omega 3) Ingredients Segment by Type

Low Concentrates
Anchovy/Sardine
High Concentrates
Salmon Oil
Algae Oil
Cod Liver Oil
Medium Concentrates
EPA & DHA (Omega 3) Ingredients Segment by Application

Infant Formulas
Pharmaceuticals
Dietary Supplements
Functional Foods
Pet & Animal Feed
EPA & DHA (Omega 3) Ingredients Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global EPA & DHA (Omega 3) Ingredients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions EPA & DHA (Omega 3) Ingredients market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify EPA & DHA (Omega 3) Ingredients significant trends, drivers, influence factors in global and regions.
6. To analyze EPA & DHA (Omega 3) Ingredients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA & DHA (Omega 3) Ingredients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EPA & DHA (Omega 3) Ingredients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA & DHA (Omega 3) Ingredients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the EPA & DHA (Omega 3) Ingredients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EPA & DHA (Omega 3) Ingredients industry.
Chapter 3: Detailed analysis of EPA & DHA (Omega 3) Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of EPA & DHA (Omega 3) Ingredients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of EPA & DHA (Omega 3) Ingredients in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global EPA & DHA (Omega 3) Ingredients Sales Value (2020-2031)
1.2.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume (2020-2031)
1.2.3 Global EPA & DHA (Omega 3) Ingredients Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 EPA & DHA (Omega 3) Ingredients Market Dynamics
2.1 EPA & DHA (Omega 3) Ingredients Industry Trends
2.2 EPA & DHA (Omega 3) Ingredients Industry Drivers
2.3 EPA & DHA (Omega 3) Ingredients Industry Opportunities and Challenges
2.4 EPA & DHA (Omega 3) Ingredients Industry Restraints
3 EPA & DHA (Omega 3) Ingredients Market by Company
3.1 Global EPA & DHA (Omega 3) Ingredients Company Revenue Ranking in 2024
3.2 Global EPA & DHA (Omega 3) Ingredients Revenue by Company (2020-2025)
3.3 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Company (2020-2025)
3.4 Global EPA & DHA (Omega 3) Ingredients Average Price by Company (2020-2025)
3.5 Global EPA & DHA (Omega 3) Ingredients Company Ranking (2023-2025)
3.6 Global EPA & DHA (Omega 3) Ingredients Company Manufacturing Base and Headquarters
3.7 Global EPA & DHA (Omega 3) Ingredients Company Product Type and Application
3.8 Global EPA & DHA (Omega 3) Ingredients Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global EPA & DHA (Omega 3) Ingredients Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 EPA & DHA (Omega 3) Ingredients Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 EPA & DHA (Omega 3) Ingredients Market by Type
4.1 EPA & DHA (Omega 3) Ingredients Type Introduction
4.1.1 Low Concentrates
4.1.2 Anchovy/Sardine
4.1.3 High Concentrates
4.1.4 Salmon Oil
4.1.5 Algae Oil
4.1.6 Cod Liver Oil
4.1.7 Medium Concentrates
4.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type
4.2.1 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Type (2020-2031)
4.2.3 Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Type (2020-2031)
4.3 Global EPA & DHA (Omega 3) Ingredients Sales Value by Type
4.3.1 Global EPA & DHA (Omega 3) Ingredients Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Type (2020-2031)
4.3.3 Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Type (2020-2031)
5 EPA & DHA (Omega 3) Ingredients Market by Application
5.1 EPA & DHA (Omega 3) Ingredients Application Introduction
5.1.1 Infant Formulas
5.1.2 Pharmaceuticals
5.1.3 Dietary Supplements
5.1.4 Functional Foods
5.1.5 Pet & Animal Feed
5.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application
5.2.1 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global EPA & DHA (Omega 3) Ingredients Sales Volume by Application (2020-2031)
5.2.3 Global EPA & DHA (Omega 3) Ingredients Sales Volume Share by Application (2020-2031)
5.3 Global EPA & DHA (Omega 3) Ingredients Sales Value by Application
5.3.1 Global EPA & DHA (Omega 3) Ingredients Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Application (2020-2031)
5.3.3 Global EPA & DHA (Omega 3) Ingredients Sales Value Share by Application (2020-2031)
6 EPA & DHA (Omega 3) Ingredients Regional Sales and Value Analysis
6.1 Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2020 VS 2024 VS 2031
6.2 Global EPA & DHA (Omega 3) Ingredients Sales by Region (2020-2031)
6.2.1 Global EPA & DHA (Omega 3) Ingredients Sales by Region: 2020-2025
6.2.2 Global EPA & DHA (Omega 3) Ingredients Sales by Region (2026-2031)
6.3 Global EPA & DHA (Omega 3) Ingredients Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global EPA & DHA (Omega 3) Ingredients Sales Value by Region (2020-2031)
6.4.1 Global EPA & DHA (Omega 3) Ingredients Sales Value by Region: 2020-2025
6.4.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Region (2026-2031)
6.5 Global EPA & DHA (Omega 3) Ingredients Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America EPA & DHA (Omega 3) Ingredients Sales Value (2020-2031)
6.6.2 North America EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe EPA & DHA (Omega 3) Ingredients Sales Value (2020-2031)
6.7.2 Europe EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific EPA & DHA (Omega 3) Ingredients Sales Value (2020-2031)
6.8.2 Asia-Pacific EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America EPA & DHA (Omega 3) Ingredients Sales Value (2020-2031)
6.9.2 South America EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Value (2020-2031)
6.10.2 Middle East & Africa EPA & DHA (Omega 3) Ingredients Sales Value Share by Country, 2024 VS 2031
7 EPA & DHA (Omega 3) Ingredients Country-level Sales and Value Analysis
7.1 Global EPA & DHA (Omega 3) Ingredients Sales by Country: 2020 VS 2024 VS 2031
7.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global EPA & DHA (Omega 3) Ingredients Sales by Country (2020-2031)
7.3.1 Global EPA & DHA (Omega 3) Ingredients Sales by Country (2020-2025)
7.3.2 Global EPA & DHA (Omega 3) Ingredients Sales by Country (2026-2031)
7.4 Global EPA & DHA (Omega 3) Ingredients Sales Value by Country (2020-2031)
7.4.1 Global EPA & DHA (Omega 3) Ingredients Sales Value by Country (2020-2025)
7.4.2 Global EPA & DHA (Omega 3) Ingredients Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.5.2 USA EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.5.3 USA EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.6.2 Canada EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.6.2 Mexico EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.8.2 Germany EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.9.2 France EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.9.3 France EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.10.2 U.K. EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.11.2 Italy EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.12.2 Spain EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.13.2 Russia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.16.2 China EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.16.3 China EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.17.2 Japan EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.18.2 South Korea EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.19.2 India EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.19.3 India EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.20.2 Australia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.22.2 Brazil EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.23.2 Argentina EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.24.2 Chile EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.25.2 Colombia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.26.2 Peru EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.28.2 Israel EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.29.2 UAE EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.30.2 Turkey EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.31.2 Iran EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt EPA & DHA (Omega 3) Ingredients Sales Value Growth Rate (2020-2031)
7.32.2 Egypt EPA & DHA (Omega 3) Ingredients Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt EPA & DHA (Omega 3) Ingredients Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Lonza
8.1.1 Lonza Comapny Information
8.1.2 Lonza Business Overview
8.1.3 Lonza EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.1.4 Lonza EPA & DHA (Omega 3) Ingredients Product Portfolio
8.1.5 Lonza Recent Developments
8.2 Omega Protein
8.2.1 Omega Protein Comapny Information
8.2.2 Omega Protein Business Overview
8.2.3 Omega Protein EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.2.4 Omega Protein EPA & DHA (Omega 3) Ingredients Product Portfolio
8.2.5 Omega Protein Recent Developments
8.3 Martek
8.3.1 Martek Comapny Information
8.3.2 Martek Business Overview
8.3.3 Martek EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.3.4 Martek EPA & DHA (Omega 3) Ingredients Product Portfolio
8.3.5 Martek Recent Developments
8.4 GC Rieber Oils
8.4.1 GC Rieber Oils Comapny Information
8.4.2 GC Rieber Oils Business Overview
8.4.3 GC Rieber Oils EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.4.4 GC Rieber Oils EPA & DHA (Omega 3) Ingredients Product Portfolio
8.4.5 GC Rieber Oils Recent Developments
8.5 DSM
8.5.1 DSM Comapny Information
8.5.2 DSM Business Overview
8.5.3 DSM EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.5.4 DSM EPA & DHA (Omega 3) Ingredients Product Portfolio
8.5.5 DSM Recent Developments
8.6 Croda
8.6.1 Croda Comapny Information
8.6.2 Croda Business Overview
8.6.3 Croda EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.6.4 Croda EPA & DHA (Omega 3) Ingredients Product Portfolio
8.6.5 Croda Recent Developments
8.7 BASF
8.7.1 BASF Comapny Information
8.7.2 BASF Business Overview
8.7.3 BASF EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.7.4 BASF EPA & DHA (Omega 3) Ingredients Product Portfolio
8.7.5 BASF Recent Developments
8.8 Axellus
8.8.1 Axellus Comapny Information
8.8.2 Axellus Business Overview
8.8.3 Axellus EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.8.4 Axellus EPA & DHA (Omega 3) Ingredients Product Portfolio
8.8.5 Axellus Recent Developments
8.9 Algae EPAX
8.9.1 Algae EPAX Comapny Information
8.9.2 Algae EPAX Business Overview
8.9.3 Algae EPAX EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.9.4 Algae EPAX EPA & DHA (Omega 3) Ingredients Product Portfolio
8.9.5 Algae EPAX Recent Developments
8.10 Aker BioMarine
8.10.1 Aker BioMarine Comapny Information
8.10.2 Aker BioMarine Business Overview
8.10.3 Aker BioMarine EPA & DHA (Omega 3) Ingredients Sales, Value and Gross Margin (2020-2025)
8.10.4 Aker BioMarine EPA & DHA (Omega 3) Ingredients Product Portfolio
8.10.5 Aker BioMarine Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 EPA & DHA (Omega 3) Ingredients Value Chain Analysis
9.1.1 EPA & DHA (Omega 3) Ingredients Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 EPA & DHA (Omega 3) Ingredients Sales Mode & Process
9.2 EPA & DHA (Omega 3) Ingredients Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 EPA & DHA (Omega 3) Ingredients Distributors
9.2.3 EPA & DHA (Omega 3) Ingredients Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.